Skin testing after anaphylaxis to a topical Neosporin preparation.
Schroer
Brian C
BC
Fox
Charity C
CC
Hauswirth
David W
DW
D000287:Administration, Topical; D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000276:immunology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D001414:Bacitracin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D008297:Male; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011112:Polymyxin B / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012882:Skin Tests
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D001414:Bacitracin; C001816:bacitracin zinc, neomycin sulfate, polymyxin B, drug combination; D009355:Neomycin; D011112:Polymyxin B